1-cyanocyclopropyl-derivatives as cathepsin K inhibitors

Details for Australian Patent Application No. 2008269513 (hide)

Owner AstraZeneca AB

Inventors Heron, Nicola Murdoch; Dossetter, Alexander Graham

Agent Davies Collison Cave

Pub. Number AU-B-2008269513

PCT Pub. Number WO2009/001129

Priority 61/042,840 07.04.08 US; 60/946,178 26.06.07 US

Filing date 24 June 2008

Wipo publication date 31 December 2008

Acceptance publication date 16 June 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4353 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/147 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2009/001129 Priority application(s): WO2009/001129

16 June 2011 Application Accepted

  Published as AU-B-2008269513

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008269516-Pyrazinone derivatives and their use in the treatment of lung diseases

2008269493-Medical aligning device